Moderna Helps Biotech ETFs Mitigate Massive Losses as Stocks Tumble

While much of the stock market and associated index ETFs are bathed in red to start the new year, Moderna is rallying, as the biotech company is boosting its vaccine output to help the spiking infection rate in the coronavirus pandemic. The much-touted biotech company is elevating its...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.